Curavi helping seniors, Fabric Genomics rapidly diagnoses rare diseases, and more portfolio company news

Several portfolio companies, including Curavi, Xealth, and Health Catalyst were featured in the news in the past month.

Xealth’s CEO was quoted in Geekwire, Health Catalyst was featured in Forbes, and both Curavi and Fabric Genomics were highlighted for the impressive work they’re doing to impact patient care. Get a closer look at each in the news below.


Curavi president and CEO, Alissa Meade was recently featured in Senior Housing News to discuss the impact Curavi solutions have had on patients. The story notes that Curavi has allowed about 95 percent of seniors to receive treatment in place with about 40 percent avoiding a transfer to a different care setting.


A new study has been published in Science Translational Medicine highlighting how Rady Children’s Institute for Genomic Medicine and its partners, including Fabric Genomics, have developed a new process to quickly diagnose rare genetic diseases. Using a proprietary algorithm, genetic variant classification and disease diagnosis were made in less than 20 hours, the fastest published diagnosis using whole-genome libraries.


health catalyst logo

Forbes recently published an article comparing potential changes in the fintech space to the health care industry. The article sites information from Health Catalyst regarding the shift to outcomes-based care, as a potential positive for banking should it move to an outcomes-based banking model.


Xealth logo image

Seattle has seen an influx of everything from jobs to funding over the past several years, all resulting in its growth as the top emerging life sciences market. Geekwire did a deep dive on the topic, speaking with Xealth CEO, Mike McSherry to get his thoughts on the market. McSherry credited the cities heavy tech background that has it uniquely positioned to continue growing and drawing talent from across the country.

You Might Also Like…

more from the newsletter